Investview, Inc.

Investview, Inc.

INVU
Investview, Inc.US flagOther OTC
0.02
USD
+0.00
- -
38.76MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.33
0.17
0.06
0.02
0.1
0.01
0.01
0.01
0.01
0.02
0.03
0.03
- -
0.02
Basic EPS, GAAP
-1.86
-0.69
-0.78
-0.14
-0.02
-0.01
- -
-0.01
- -
-0.01
- -
- -
- -
-0.01
Free Cash Flow per Basic Share
-0.21
-0.2
-0.23
-0.07
-0.01
- -
- -
- -
- -
- -
- -
0.01
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-17
-14.86
-8.4
-6.72
-0.04
-0.01
-0.01
-0.01
-0.01
-0.03
-0.03
-0.04
- -
-0.05
Tangible Book Value per Share
-1.08
-1.03
-0.24
-0.31
-0.03
- -
- -
- -
- -
0.01
0.01
0.01
- -
- -
Basic Weighted Avg Shares
5
6
12
15
126
2,170
2,640
3,214
2,982
2,678
2,559
1,908
- -
1,853
Sales/Revenue/Turnover
2
1
1
- -
13
18
30
24
38
62
68
52
36
30
Operating Margin (%)
-441.73
-284.94
-692.21
-470.38
-15.05
-59.59
-13.29
-37.6
3.2
9.31
10.14
6.96
-20.58
-32.65
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
1
2
6
4
4
1
1
Net Income, GAAP
-9
-4
-9
-2
-2
-15
-5
-21
1
-13
3
1
-9
-12
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
43.48
42.92
- -
0.23
Profit Margin (%)
-562.04
-396.07
-1,292.35
-594.6
-18.86
-83.23
-16.9
-88.02
1.48
-20.93
4.17
2.27
-24.58
-40.23
Working Capital
-3
-5
-1
-3
-4
-4
-2
-14
2
14
12
16
12
2
LT Debt
3
1
2
2
- -
- -
- -
- -
13
6
2
2
2
2
Total Equity
-5
-6
-3
-5
-4
-2
1
-14
-4
17
19
17
9
5
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
112.01
- -
15.45
9.55
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
-21.83
- -
-4.49
-2.34
- -
-1.37
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
1
1
1
LT Borrowings
2
2
2
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,851
1,848
1,846
Market Capitalization
45
53
52

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
21
18
8
Cash, Cash Equivalents & STI
15
10
5
Accounts Receivable, Net
3
1
- -
Inventories
1
1
1
Total Current Liabilities
9
6
6
Payables & Accruals
5
4
4
ST Debt
1
1
1
Deferred Revenue
2
1
1

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-202.39%
-138.47%
-48.11%
Free Cash Flow
-93.4%
-198.09%
-131.34%
Net Income, GAAP
-280.76%
-703.73%
-848.26%
Sales/Revenue/Turnover
364.94%
15.2%
-30.79%
Total Cash Common Dividend
- -
-43.33%
-1.79%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
16
13
12
12
52
2025
10
10
9
7
36
2026
4
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Victor Miguel Oviedo
Full Time Employees
33
Sector
Technology
Industry
Software - Application
Address
The Summit Group Building, Building A Haverford NJ United States of America 07724
IPO Date
Jan 14, 2000
Business
Investview, Inc. (INVU) operates as a diversified financial technology services company offering products and services across financial education, blockchain technology, cryptocurrency mining, brokerage trading, and health and wellness manufacturing in the United States and internationally. Founded in 2013 and headquartered in Haverford, Pennsylvania, the company conducts its activities through subsidiaries including iGenius, which delivers financial education tools, research, analysis, investment content, and products via a global multi-level marketing network of independent distributors targeting self-directed investors in equities, options, FOREX, ETFs, binary options, and cryptocurrency; SAFETek, which provides large-scale Bitcoin mining, blockchain infrastructure management, and crypto mining services leveraging sustainable energy sources; Renu Laboratories, an FDA-registered manufacturer of proprietary over-the-counter skincare, personal care, hair care, cosmetics, nutritional supplements, and wellness products for wholesale, retail, and direct-to-consumer markets through the myLife Wellness division; and Investview Financial Group Holdings, which offers self-directed brokerage services, institutional trade execution, advisory services, codeless algorithmic trading technologies, and a forthcoming mobile trading platform with AI-powered solutions. In October 2024, Investview acquired Renu Laboratories Inc., integrating its manufacturing capabilities to expand proprietary health, beauty, and wellness offerings and projecting revenue contributions starting in Q4 2024 through Q1 2025 via synergies with the iGenius distribution network; the company also reported strong 2024 financial results including $55.4 million in gross revenue, $8.3 million in net cash from operations, and a share repurchase program, while settling outstanding obligations in January 2025 to strengthen its balance sheet.

Company News

APIChat
  • Investview Announces Strategic Leadership Alignment with Josh Zwagil and the AkashX Business Network to Strengthen Conectiv’s Global Direct-to-Consumer Marketing Platform

  • Investview Announces Strategic Leadership Alignment with Josh Zwagil and the AkashX Business Network to Strengthen Conectiv's Global Direct-to-Consumer Marketing Platform

  • Investview, Inc. (“INVU”) Reports Financial Results and Operational Highlights for the First Quarter Ended March 31, 2026

  • Investview (OTCMKTS:INVU) Share Price Passes Below 200-Day Moving Average – Should You Sell?

  • Investview, Inc. (“INVU”) Reports Full Year 2025 Financial Results, Operational Highlights, and a Year-End Message from the CEO

  • Investview, Inc. Announces Rebrand of Subsidiary iGenius to Conectiv, Reflecting Strategic Expansion into Health, Wellness, and Lifestyle Offerings

  • Investview Announces Official Launch of myLife Wellness, Establishing a New Consumer Health & Wellness Business Unit

  • Investview Strengthens Board with New Appointment of Robert Verdun to Board of Directors

  • Investview Announces iGenius Leadership Alignment with Industry Leader David Imonitie

  • Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights for the Third Quarter Ended September 30, 2025

  • Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights for the Second Quarter Ended June 30, 2025

  • Investview, Inc. (“INVU”) Reports Financial Results and Current Operational and Financial Highlights for the First Quarter Ended March 31, 2025

  • Investview, Inc. (“INVU”) Reports Full Year 2024 Financial Results, Operational Highlights and a Year-End Message from the CEO

  • INVESTVIEW, INC. ANNOUNCES LAUNCH OF STOCK REPURCHASE PROGRAM

  • Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights for the Third Quarter Ended September 30, 2024

  • Investview, Inc. (“INVU”) Announces the Acquisition of Renu Laboratories Inc., a manufacturer of proprietary and other health, beauty and wellness products.

  • Investview, Inc. (“INVU”) Reports Financial Results, Current Operational and Financial Highlights for the First Quarter Ended March 31, 2024

  • Investview, Inc. (“INVU”) Reports Full Year 2023 Financial Results, Operational Highlights and a Year-End Message from the CEO

  • Investview to Expand into the Securities Brokerage Business - Completes the Acquisition of Broker-Dealer, “Opencash Securities, LLC”. - Updated

  • Investview to Expand into the Securities Brokerage Business - Completes the Acquisition of Broker-Dealer, “Opencash Securities, LLC”.